Log In
Print
BCIQ
Print
Print this Print this
 

rilapladib (SB 659032)

Also known as: 659032

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionSmall molecule inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2)
Molecular Target Lipoprotein-associated phospholipase A2 (PLA2G7) (PAFAH) (Lp-PLA2)
Mechanism of ActionLipoprotein-associated phopholipase A2 (Lp-PLA2) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today